Treatment of neuropsychiatric syndromes in multiple sclerosis.
The treatment of multiple sclerosis has been revolutionized during the past 10 years by the introduction of disease-modifying therapies. However, day-to-day management of the symptoms and complications of this condition will, for the foreseeable future, continue to be important management concerns. Among the most problematic and troublesome manifestations of multiple sclerosis are its neuropsychiatric manifestations. Most prominent among these are depression, pathologic laughing and crying, fatigue, cognitive problems, sleep disorders and disorders of sexual function. There have been relatively few randomized controlled trials of pharmacologic treatments for these conditions. Available treatments for the management of fatigue and cognitive deficits remain inadequate and patients must often accommodate these symptoms in their lifestyle.
Patten
Scott B
SB
University of Calgary, Department of Community Health Sciences, Alberta, Canada. patten@ucalgary.ca
D003865:Major Depressive Disorder / Q000150:complications / Q000523:psychology / Q000628:therapy; D005221:Fatigue / Q000150:complications / Q000523:psychology / Q000628:therapy; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000523:psychology* / Q000628:therapy*; D009103:Multiple Sclerosis / Q000150:complications / Q000523:psychology* / Q000628:therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000150:complications / Q000523:psychology / Q000628:therapy; D013577:Syndrome
D011619:Psychotropic Drugs